Table 4.
individual cost effectiveness | individual cost effectiveness | ||
---|---|---|---|
WOMAC index [%] before TKA | ≤100 €/% | > 100 €/% | |
before pathway implementation | |||
≤ 40% | 25% | 75% | |
> 40% | 52% | 48% | |
after pathway implementation, without personal briefing | |||
≤ 40% | 24% | 76% | |
> 40% | 56% | 44% | |
after pathway implementation and personal briefing | |||
≤ 40% | 13% | 87% | |
> 40% | 47% | 53% |
relative frequencies of individual cost effectiveness ratios ≤ 100 €/% between partial cost sum {€] from the hospital's perspective and three months WOMAC change after TKA [%], assessed in 132 patients, who underwent TKA before implementation of a critical pathway on TKA, versus 128 patients, who underwent TKA after path implementation (the latter being stratified for attendance of a personal briefing as a voluntary part of the pathway), stratified for the patients' total WOMAC osteoarthritis index before surgery [„≤ 40%" versus „> 40%"]